India's cheap weight-loss drugs could reshape global obesity fight - With India's semaglutide patent expiring on 20 Marc...
India's cheap weight-loss drugs could reshape global obesity fight With India's semaglutide patent expiring on 20 March, about 50 branded generics are expected to enter the market…
India's cheap weight-loss drugs could reshape global obesity fight
With India's semaglutide patent expiring on 20 March, about 50 branded generics are expected to enter the market.
READ MORE...
@BBCWorldoffl
.
Bbc
India's cheap weight-loss drugs could reshape global obesity fight
With India's semaglutide patent expiring on 20 March, about 50 branded generics are expected to enter the market.
Source: https://t.me/BBCWorldoffl/73952